Clinical Trials Logo

Traumatic Brain Injury clinical trials

View clinical trials related to Traumatic Brain Injury.

Filter by:

NCT ID: NCT00171795 Completed - Clinical trials for Traumatic Brain Injury

Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment

Start date: November 2002
Phase: Phase 3
Study type: Interventional

This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with traumatic brain injury and cognitive impairment.

NCT ID: NCT00170352 Completed - Clinical trials for Traumatic Brain Injury

Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury

Start date: November 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to study the effects of EARLY (no more than 24 four hours from injury) administration of extra amounts of oxygen on traumatic brain injury.

NCT ID: NCT00163826 Completed - Clinical trials for Traumatic Brain Injury

Spinal Clearance Study: Expediting the Spinal Clearance Process in the Major Trauma Patient

Start date: March 2004
Phase: Phase 4
Study type: Observational

The Alfred Hospital receives approximately 40% of the major trauma patients in Victoria, all of whom are at risk for spinal injuries. The potential for spinal injuries necessitates the undertaking of appropriate spinal investigations, and a delay in the completion of these investigations exposes the patient to the risk of a missed diagnosis of spinal instability and of complications of immobility; the potential spinal patient is required to wear a neck collar and be nursed lying flat whilst awaiting the completion and the appropriate documentation of spinal X-ray investigations. The purpose of this study is to identify the issues causing a delay in the process of the completion of the appropriate spinal investigations and the documentation of the results. The outcome of the proposed research will be the development of a clinical management protocol to expedite the process, with the aim of optimising patient care and reducing complications.

NCT ID: NCT00163774 Completed - Clinical trials for Traumatic Brain Injury

Intensive Monitoring of Brain Injured Patients

Start date: November 2002
Phase: N/A
Study type: Interventional

Analysis of cerebral blood flow (CBF) and oxygenation using complementary focal and global monitoring techniques will permit the delivery of more informed individualised and 'targeted' therapy on the patient with severe head injury, reduce episodes of secondary brain injury and therefore improve outcomes. Aims - To develop a deeper understanding of Cerebral Blood Flow and auto-regulation for TBI patients based on the results of data collected in patients post TBI. - To establish the basis for further multi modality clinical trials in severely brain injured patients in the future. - To improve understanding of the various secondary processes that continue to cause neuronal damage after the initial injury, and therefore affect patient outcome. - To proceed to the second phase of the study, with the introduction of algorithms for treatment.

NCT ID: NCT00141674 Completed - Clinical trials for Traumatic Brain Injury

Age of Blood in Brain Injury

Start date: March 2005
Phase: N/A
Study type: Interventional

Donated red blood cells vary in how old they are, that is, how long they have been stored since being collected from donors. Blood that has been donated is stored for a maximum of 42 days, after this time it is expired. That means that red blood cells that are given to patients as a blood transfusion can be anywhere from a few days old to 42 days old. The average age of blood that is given as a blood transfusion in this hospital is 21 days old. As stored blood gets older its ability to carry oxygen may be reduced. Whether or not this is important in patients with a brain injury is not currently known. The purpose of this study is to try and determine if fresh blood (less than 5 days old) is better than old blood (greater than 20 days old) in improving the supply of oxygen in patients who have suffered an injury to their brain.

NCT ID: NCT00132249 Completed - Clinical trials for Traumatic Brain Injury

Vietnam Head Injury Study - Phase III

Start date: April 2004
Phase:
Study type: Observational

The Vietnam Head Injury Study (VHIS)-Phase III is a prospective, long-term follow-up study of head-injured Vietnam veterans. The purpose of this research study is to determine the long-term consequences, if any, of head injury.

NCT ID: NCT00129857 Completed - Clinical trials for Traumatic Brain Injury

Dexanabinol in Severe Traumatic Brain Injury

Start date: January 2001
Phase: Phase 3
Study type: Interventional

Each year a large number of patients are hospitalized at Shock Trauma Centers with severe head injuries. Bleeding into and swelling of these patients' brains may cause compression of vital structures, disability and death. Sometimes surgery is needed. Unfortunately, the investigators have no medication to treat the bad effects of head trauma. Part of the brain damage is due to toxic chemicals (including one called glutamate) that are released by the damaged nerves. Dexanabinol may prevent some of the bad effects of glutamate on the brain and may protect the brain against uncontrollable swelling and death.

NCT ID: NCT00061399 Completed - Clinical trials for Traumatic Brain Injury

Prospective Memory in Children With Traumatic Brain Injury

Start date: July 2002
Phase: N/A
Study type: Observational

Prospective memory (PM) is memory to complete future tasks, such as recalling to give a note to someone when you next see them, pick up milk on the way home, or remembering to keep an appointment. This study will evaluate PM in children with traumatic brain injury (TBI).

NCT ID: NCT00056524 Completed - Stroke Clinical Trials

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Start date: February 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect (episodes of uncontrolled crying and/or laughter).

NCT ID: NCT00048646 Completed - Clinical trials for Traumatic Brain Injury

Progesterone Treatment of Blunt Traumatic Brain Injury

Start date: May 2002
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if progesterone treatment safely reduces brain swelling and damage after injury.